PMID- 29686544
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240323
IS  - 0899-8280 (Print)
IS  - 1525-3252 (Electronic)
IS  - 0899-8280 (Linking)
VI  - 31
IP  - 1
DP  - 2018 Jan
TI  - Thrombolytic use in the region around Amarillo, Texas, in patients with ST 
      elevation myocardial infarction.
PG  - 9-11
LID - 10.1080/08998280.2017.1400877 [doi]
AB  - Appropriate administration of thrombolytic therapy is particularly important for 
      ST elevation myocardial infarction (STEMI) patients who are unable to access 
      primary percutaneous coronary intervention (PCI) in a timely manner. We evaluated 
      the current state of thrombolytic therapy in the Panhandle region of West Texas 
      where access to primary PCI is poor. The medical records of 79 patients 
      transferred from 20 outlying facilities to the two hospitals in Amarillo, Texas, 
      for STEMI in 2016 were retrospectively evaluated for time of onset of chest pain, 
      initial electrocardiogram findings, medication reconciliation, and any 
      contraindications to thrombolytic therapy. Medical record review allowed the 
      patients to be sorted into one of five predefined categories based on our 
      findings. The most common error discovered was failure to deliver the appropriate 
      accompanying medications with thrombolytic therapy, noted in 43% of patients. 
      Other errors included failure to deliver thrombolytic therapy in patients who met 
      no clear contraindications to thrombolytic therapy (21%) and administering 
      thrombolytic therapy to patients who had not suffered STEMI (4%). Thirteen 
      percent of patients were appropriately treated with thrombolytic therapy and 19% 
      of patients met a contraindication to thrombolytic therapy and were not treated 
      with thrombolytic therapy, as was appropriate.
FAU - McMaster, Kelly S
AU  - McMaster KS
AD  - Department of Internal Medicine, Texas Tech University Health Sciences Center 
      School of Medicine-Amarillo, Amarillo, Texas.
FAU - Chatterjee, Totini
AU  - Chatterjee T
AD  - Department of Internal Medicine, Texas Tech University Health Sciences Center 
      School of Medicine-Amarillo, Amarillo, Texas.
FAU - McBrayer, Drew
AU  - McBrayer D
AD  - Department of Internal Medicine, Texas Tech University Health Sciences Center 
      School of Medicine-Amarillo, Amarillo, Texas.
FAU - Brabham, David
AU  - Brabham D
AD  - Department of Internal Medicine, Cardiology Center of Amarillo and Texas Tech 
      University Health Sciences Center School of Medicine-Amarillo, Amarillo, Texas.
LA  - eng
PT  - Journal Article
DEP - 20180201
PL  - United States
TA  - Proc (Bayl Univ Med Cent)
JT  - Proceedings (Baylor University. Medical Center)
JID - 9302033
PMC - PMC5903524
OTO - NOTNLM
OT  - Acute coronary syndrome
OT  - ST-elevation myocardial infarction
OT  - dual antiplatelet therapy
OT  - thrombolytic therapy
EDAT- 2018/04/25 06:00
MHDA- 2018/04/25 06:01
PMCR- 2018/02/01
CRDT- 2018/04/25 06:00
PHST- 2018/04/25 06:00 [entrez]
PHST- 2018/04/25 06:00 [pubmed]
PHST- 2018/04/25 06:01 [medline]
PHST- 2018/02/01 00:00 [pmc-release]
AID - 1400877 [pii]
AID - 10.1080/08998280.2017.1400877 [doi]
PST - epublish
SO  - Proc (Bayl Univ Med Cent). 2018 Feb 1;31(1):9-11. doi: 
      10.1080/08998280.2017.1400877. eCollection 2018 Jan.